Newsfeeds Archive - Page 2 of 3

1 minute read

ANI Pharmaceuticals Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed

May 11, 4:35 PM

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) ("ANI") today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will

ANIP

4 minute read

Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

May 8, 12:59 PM

Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.

ANIP

1 minute read

Why ANI Pharmaceuticals Stock Is Soaring Today

By Vandana Singh

May 8, 11:17 AM

ANI Pharmaceuticals Inc's (NASDAQ: ANIP) Q1 revenues were $106.8 million, +65.6% Y/Y, beating the

ANIP

2 minute read

Six Flags Entertainment, Zscaler, Energizer And Other Big Stocks Moving Higher On Monday

By Lisa Levin

May 8, 10:40 AM

U.S. stocks traded lower, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording gains in today’s session.

ANIP

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

May 8, 9:06 AM

Gainers Bellicum Pharmaceuticals (NASDAQ:BLCM) stock rose 135.4% to $0.94 during Monday’s pre-market session. The market value of their…

ADTX

13 minute read

Earnings

Earnings Scheduled For May 8, 2023

By Benzinga Insights

May 8, 9:03 AM

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.

ACAD

1 minute read

Earnings

Earnings Preview For ANI Pharmaceuticals

By Benzinga Insights

May 5, 3:02 PM

ANI Pharmaceuticals (NASDAQ:ANIP) is set to give its latest quarterly earnings report on Monday, 2023-05-08. Here’s what investors…

ANIP

10 minute read

Earnings

Earnings Scheduled For March 9, 2023

By Benzinga Insights

March 9, 9:00 AM

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.

ACHR

1 minute read

ANI Pharmaceuticals Sees FY23 Adjusted EPS of $2.09-$2.59 Vs. Consensus Of $2.62; Forecasts Revenues Of $360M-$385M Vs. $352.49M Estimate

By Benzinga Newsdesk

March 9, 8:00 AM

2023 Cortrophin specific revenue guidance is between $80.0 million to $90.0 million, representing 92% to 116% growth as compared to $41.7 million recognized in

ANIP

1 minute read

Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch

By Vandana Singh

March 1, 3:16 PM

Guggenheim launched its coverage on ANI Pharmaceuticals Inc (NASDAQ:ANIP) with a price target of $55 and a Buy recommendation citing a “bullish view”…

ANIP